VHL
Click for more information
7.69% 14.0¢ virax holdings limited

Previous trials with TCN-P, page-7

  1. Legume
    5,583 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    23/10/14
    16:00
    Post #: 14171302
    Trep, I should've added in-vitro. The TCN-P appears to buildup in liver and kidney tissues once it's administered into live subjects.
    VHL Price at posting: 0.8¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add VHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.